Biopharmaceutics, BCS & Bioavailability

Cmax

After you take a drug, its concentration in the blood rises as it is absorbed, reaches a high point, then falls as the body clears it. Cmax is that high point — the single highest plasma concentration the drug achieves during a dosing interval. Think of it as the crest of a wave: how tall the wave gets tells you how intense the exposure briefly becomes.

Cmax (typically reported in units like ng/mL or µg/mL) is read directly off the measured plasma concentration-time curve, with no curve-fitting required. It reflects the balance between how fast the drug is delivered into the blood and how fast it is removed: a faster or more complete absorption, or a slower clearance, pushes Cmax higher. Together with Tmax (the time at which it occurs) it characterizes the rate of absorption.

Clinically, Cmax matters because it is often tied to peak effects and to dose-related side effects — a Cmax that overshoots can mean toxicity, one that falls short may mean the drug never reaches a working level. That is why bioequivalence studies compare Cmax (alongside AUC) between products, and why modified-release formulations are designed to blunt the peak and smooth out the curve.

Also called
peak plasma concentration峰浓度尖峰血漿濃度